2025
SJR Q1
JCR Q1 · 5,2
190 matched articles
SCIE
Journal detail
Chemico-Biological Interactions
- Publisher
- Elsevier Ireland Ltd
- Country
- Ireland · Western Europe
- Type
- journal
- ISSN
-
0009279718727786
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,23
- Quartile Q1
- H-Index 160
- Cites/doc 5,67
- Docs (3y) 1.143
- Cites (3y) 7.208
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 5,2
- 5Y JIF 5,5
- JCI 1,18
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Medicine (miscellaneous) Q1
- Toxicology Q1
Areas
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Biochemistry & Molecular Biology | Pharmacology & Pharmacy | Toxicology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,23 | 5,2 | 5,5 | 1,18 | Q1 | 160 |
| 2024 | Q1 | Q1 | 1,12 | 5,4 | 5,1 | 1,23 | Q1 | 152 |
| 2023 | Q1 | Q1 | 0,946 | 4,7 | 4,6 | 1,16 | Q1 | 152 |
| 2022 | Q1 | Q1 | 0,866 | 5,1 | 4,9 | 1,17 | Q1 | 152 |
| 2021 | Q1 | Q1 | 0,857 | 5,2 | 4,9 | 1,17 | Q1 | 152 |
| 2020 | Q2 | Q1 | 0,943 | 5,2 | 4,6 | 1,18 | Q1 | 152 |
| 2019 | Q1 | Q1 | 0,896 | 3,7 | 3,6 | 1,14 | Q1 | 152 |
| 2018 | — | Q2 | — | 3,4 | 3,3 | 1,11 | Q1 | — |
| 2017 | Q1 | Q2 | 1,033 | 3,3 | 3,3 | 1,11 | Q1 | 152 |
| 2016 | Q1 | Q2 | 1,029 | 3,1 | 3,2 | — | — | 152 |
| 2015 | Q1 | Q2 | 1,069 | 2,6 | 2,9 | — | — | 152 |
| 2014 | Q1 | Q2 | 0,995 | 2,6 | 2,8 | — | — | 152 |
| 2013 | Q1 | Q2 | 1,097 | 3 | 3,2 | — | — | 152 |
| 2012 | Q1 | Q2 | 1,099 | 3 | 3 | — | — | 152 |
| 2011 | Q1 | Q2 | 1,019 | 2,9 | 3,1 | — | — | 152 |
| 2010 | Q1 | Q2 | 0,959 | 2,8 | 3,3 | — | — | 152 |
| 2009 | — | Q2 | — | 2,5 | 3 | — | — | — |
| 2008 | — | Q1 | — | 3,1 | 2,9 | — | — | — |
| 2007 | — | Q1 | — | 3,1 | 3,1 | — | — | — |
| 2006 | — | Q3 | — | 1,8 | — | — | — | — |
| 2005 | — | Q2 | — | 2 | — | — | — | — |
| 2004 | — | Q1 | — | 2,8 | — | — | — | — |
| 2003 | — | Q2 | — | 1,6 | — | — | — | — |
| 2002 | — | Q3 | — | 1,3 | — | — | — | — |
| 2001 | — | Q1 | — | 1,7 | — | — | — | — |
| 2000 | — | Q1 | — | 1,7 | — | — | — | — |
| 1999 | — | Q1 | — | 1,9 | — | — | — | — |
| 1998 | — | Q2 | — | 1,2 | — | — | — | — |
| 1997 | — | Q1 | — | 1,6 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 80/328 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 62/356 |
| 2025 | TOXICOLOGY | SCIE | Q1 | Q1 | 16/106 |
| 2024 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 61/320 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 38/352 |
| 2024 | TOXICOLOGY | SCIE | Q1 | Q1 | 12/106 |
| 2023 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 70/313 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 55/354 |
| 2023 | TOXICOLOGY | SCIE | Q1 | Q1 | 16/106 |
| 2022 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q1 | 78/285 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 56/278 |
| 2022 | TOXICOLOGY | SCIE | Q1 | Q1 | 13/94 |
| 2021 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q1 | 102/297 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 73/279 |
| 2021 | TOXICOLOGY | SCIE | Q1 | Q1 | 18/94 |
| 2020 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q1 | 83/295 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 56/276 |
| 2020 | TOXICOLOGY | SCIE | Q1 | Q1 | 15/93 |
| 2019 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q1 | 113/297 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 73/271 |
| 2019 | TOXICOLOGY | SCIE | Q1 | Q1 | 16/92 |
| 2018 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q1 | 120/299 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 79/267 |
| 2018 | TOXICOLOGY | SCIE | Q2 | Q1 | 30/93 |
| 2017 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q1 | 115/293 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 75/261 |
| 2017 | TOXICOLOGY | SCIE | Q2 | Q1 | 24/94 |
| 2016 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 123/290 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 77/257 |
| 2016 | TOXICOLOGY | SCIE | Q2 | — | 27/92 |
| 2015 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 148/289 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 98/255 |
| 2015 | TOXICOLOGY | SCIE | Q2 | — | 34/90 |
| 2014 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 155/290 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 110/255 |
| 2014 | TOXICOLOGY | SCIE | Q2 | — | 40/88 |
| 2013 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 133/291 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 79/256 |
| 2013 | TOXICOLOGY | SCIE | Q2 | — | 28/87 |
| 2012 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 130/290 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 75/261 |
| 2012 | TOXICOLOGY | SCIE | Q2 | — | 28/85 |
| 2011 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 143/290 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 89/261 |
| 2011 | TOXICOLOGY | SCIE | Q2 | — | 28/83 |
| 2010 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 141/286 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 85/252 |
| 2010 | TOXICOLOGY | SCIE | Q2 | — | 29/83 |
| 2009 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 156/283 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 110/237 |
| 2009 | TOXICOLOGY | SCIE | Q2 | — | 33/77 |
| 2008 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 109/275 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 63/219 |
| 2008 | TOXICOLOGY | SCIE | Q1 | — | 18/75 |
| 2007 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 103/263 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 59/205 |
| 2007 | TOXICOLOGY | SCIE | Q1 | — | 11/73 |
| 2006 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 180/262 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 106/199 |
| 2006 | TOXICOLOGY | SCIE | Q3 | — | 40/76 |
| 2005 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 161/261 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 91/193 |
| 2005 | TOXICOLOGY | SCIE | Q2 | — | 25/75 |
| 2004 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 107/261 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 49/187 |
| 2004 | TOXICOLOGY | SCIE | Q1 | — | 11/75 |
| 2003 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 178/261 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 99/185 |
| 2003 | TOXICOLOGY | SCIE | Q2 | — | 38/77 |
| 2002 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 188/266 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 114/188 |
| 2002 | TOXICOLOGY | SCIE | Q3 | — | 45/76 |
| 2001 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 169/308 |
| 2001 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 16/36 |
| 2001 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 25/118 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 71/186 |
| 2001 | TOXICOLOGY | SCIE | Q2 | — | 24/78 |
| 2000 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 173/310 |
| 2000 | BIOLOGY | SCIE | Q2 | — | 18/51 |
| 2000 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 15/35 |
| 2000 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q1 | — | 26/118 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 70/181 |
| 2000 | TOXICOLOGY | SCIE | Q2 | — | 23/77 |
| 1999 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 138/295 |
| 1999 | BIOLOGY | SCIE | Q2 | — | 15/53 |
| 1999 | CHEMISTRY | SCIE | Q1 | — | 22/121 |
| 1999 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 8/30 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 50/175 |
| 1999 | TOXICOLOGY | SCIE | Q1 | — | 14/74 |
| 1998 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 180/295 |
| 1998 | BIOLOGY | SCIE | Q2 | — | 23/66 |
| 1998 | CHEMISTRY | SCIE | Q2 | — | 33/126 |
| 1998 | CHEMISTRY, MEDICINAL | SCIE | Q3 | — | 18/30 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 81/178 |
| 1998 | TOXICOLOGY | SCIE | Q2 | — | 31/71 |
| 1997 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 131/253 |
| 1997 | BIOLOGY | SCIE | Q2 | — | 19/63 |
| 1997 | CHEMISTRY | SCIE | Q1 | — | 24/111 |
| 1997 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 11/28 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 50/157 |
| 1997 | TOXICOLOGY | SCIE | Q1 | — | 15/63 |